Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors

Pediatric Blood and Cancer

Volumn 50, Issue 1, 2008, Pages 29-32

  Michalowski, Mariana Bohns ^a,b   De Fraipont, Florence ^a,b   Plantaz, Dominique ^a   Michelland, Sylvie ^a,b   Combaret, Valérie ^c   Favrot, Marie Christine ^a,b,d  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c CENTRE LÉON BÉRARD   (France)

^d CHU La Tronche and University   (France)

Author keywords

Cancer; Epigenetics; Methylation; Neuroblastoma (NB)

Indexed keywords

RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ARTICLE; CANCER DIAGNOSIS; CANCER RELAPSE; CANCER STAGING; GENE AMPLIFICATION; GENE MUTATION; HUMAN; INFANT; METHYLATION; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL;

CASPASE 8; CHILD, PRESCHOOL; DNA METHYLATION; EPIGENESIS, GENETIC; GENES, TUMOR SUPPRESSOR; HUMANS; INFANT; NEUROBLASTOMA; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 36849062057     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21279     Document Type: Article

References (10)

1. Myohanen SK, Baylin SB, Herman JG. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 1998;58:591-593.
2. Teitz T, Wei T, Valentine MB, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000;6:529-535.
3. van Noesel MM, van Bezouw S, Salomons GS, et al. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation, Cancer Res 2002;62:2157-2161.
4. Plantaz D, Vandesompele J, Van Roy N, et al. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer 2001;91:680-686.
5. de Fraipont F, Moro-Sibilot D, Michelland S, et al. Promoter methylation of genes in bronchial lavages: A marker for early diagnosis of primary and relapsing non-small cell lung cancer? Lung Cancer 2005;50:199-209.
6. Michalowski MB, De Fraipont F, Michelland S, et al. Methylation of RASSF1A and TRAIL pathway related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. Cancer Genet Cytogenet 2006;166:74-81.
7. Banelli B, Gelvi I, Di Vinci A, et al. Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors. Oncogene 2005;24:5619-5628.
8. Harada K, Toyooka S, Maitra A, et al. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 2002;21:4345-4349.
9. Alaminos M, Davalos V, Cheung NKV, et al. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J Natl Cancer Inst 2004;96:1208-1219.
10. Abe M, Ohira M, Kaneda A, et al. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastoma. Cancer Res 2005;65:828-834.